收藏切换
Cytotoxicity Testing of Relevant Components of Medical Polyurethane
收藏切换
Min YANG, Chengchao HUANG, Tao ZENG, Ye LI, Huangjing LIN*
Chinese Journal of Pharmaceuticals | 2025, 56(9) : 1211 - 1214
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2025, 56(9): 1211-1214
• Paper •
Cytotoxicity Testing of Relevant Components of Medical Polyurethane
Full
Min YANG, Chengchao HUANG, Tao ZENG, Ye LI, Huangjing LIN*
Affiliations
  • NMPA Key Lab. for Compatibility Studies of Pharmaceutical Products and Packaging Materials, Pharmaceutical Packaging Material Research & Inspection Center, Shanghai Modern Pharmaceutical Engineering Research Center Co., Ltd., National Advanced Medical Engineering Research Center, Shanghai 201203
Published: 2025-09-10 doi: 10.16522/j.cnki.cjph.2025.09.013
Outline
收藏切换

Cytotoxicity tests were conducted to evaluate the biosafety of medical polyurethane(PU) products. In this study, cytotoxicity tests of PU products mainly composed of bis(4-isocyanatocyclohexyl) methane(HMDI) and poly(tetramethylene ether) glycol(PTMEG) were conducted. The cytotoxicity of the PU products, raw materials and additives in the formulations were tested respectively according to the MTT method. The results showed that PU had no acute systemic toxicity, but the cell viability of PU was less than 50%, which indicated a cytotoxic potential. This laboratory prepared a small-batch of PU samples using the same formulation as commercial products, which passed acute systemic toxicity tests but exhibited only 8% cell viability. After acetone cleaning, the cell viability increased to 60%. The cell viabilities of the formulations containing HMDI and the additives such as chain extenders, antioxidants, light stabilizers and catalysts were more than 70% in the cytotoxicity test, indicating no cytotoxicity. However, the cell viability of PTMEG-containing formulations was less than 70%, with viability decreasing as concentration increased, indicating that PTMEG might be the primary cause of PU cytotoxicity. It is recommended to adjust the proportion of PTMEG or replace it with polyols exhibiting superior biosafety performance in PU products, and optimize the cleaning process during production to ensure the biosafety of PU.

cytotoxicity  /  polyurethane for medical use  /  poly(tetramethylene ether) glycol  /  polymer material  /  biosafety
杨敏, 黄成超, 曾涛, 李烨, 林黄静. 医药用聚氨酯相关成分的细胞毒性测试. 中国医药工业杂志, 2025 , 56 (9) : 1211 -1214 . DOI: 10.16522/j.cnki.cjph.2025.09.013
Min YANG, Chengchao HUANG, Tao ZENG, Ye LI, Huangjing LIN. Cytotoxicity Testing of Relevant Components of Medical Polyurethane[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (9) : 1211 -1214 . DOI: 10.16522/j.cnki.cjph.2025.09.013
Year 2025 volume 56 Issue 9
27
5
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.09.013
  • Receive Date:2025-04-22
  • Online Date:2026-11-18
  • Published:2025-09-10
Article Data
Affiliations
History
  • Received:2025-04-22
Affiliations
    NMPA Key Lab. for Compatibility Studies of Pharmaceutical Products and Packaging Materials, Pharmaceutical Packaging Material Research & Inspection Center, Shanghai Modern Pharmaceutical Engineering Research Center Co., Ltd., National Advanced Medical Engineering Research Center, Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.09.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT